The high prevalence of comorbid substance abuse and mental illness, and the challenges associated with treatment, mean that underutilization and lack of research are likely to have a critical impact on client outcomes. This paper explores evidence for the safety and efficacy of pharmacotherapy for substance use disorders in clients with comorbid mental illness. It was hypothesized that use of such medications carries risks unique to this client group, and that pharmacotherapy nonetheless has a role in treating substance dependence for these clients. The MNCat and Google Scholar research databases were searched for publications addressing the use of FDA-approved medications for alcohol and opioid dependence in clients with comorbid psychiatric diagnoses. Controlled, double-blind, and large-scale studies were prioritized.
They go further to say the reason is because of mental decline and out of financial necessity because of the high cost of healthcare. Additionally, the abuse among ... ... middle of paper ... ... abuse the issuing of prescriptions medications. Additionally, because of the grasp and scope that prescription drug abuse has communities are implementing better educational programs and resources that can help individuals managing the disorder. As I suspected, prescription drug abuse is vast problem. I am glad that I had the opportunity to see how big the issue is and the effects this type of addiction has.
Clayton Farris Naff. Detroit: Greenhaven Press, 2013. At Issue. Opposing Viewpoints in Context. Web.